NewSPACInsider launches AI-powered access to its SPAC databaseLearn more →

Latest SPAC News from SPACInsider

SPAC IPO Terms Tracker: November 6, 2026

Terms Tracker for the Week Ending November 6, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. There were no IPOs priced this week, so the November monthly IPO count starts at zero, but deal announcements did the heavy lifting with five business combinations announced. ...
Kristi Marvin · 2026-11-07 at 10:02am
SPAC IPO Terms Tracker: November 6, 2026

More in Market Intel

View all

Armada III (AACI) to Combine with Brains Bioceutical in $892M Deal

Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. ...

Morning SPAC News Roundup: November 6, 2026

At the SPAC of Dawn A familiar name was appended to the prospectus of the latest SPAC to file for an IPO as Kartoon Studios (NYSE:KACQ.U) put in its paperwork yesterday. It is to be underwritten by EF Hutton, making it the first SPAC to carry that name since the firm went through high-profile split among its management in November 2024. ...
Market Intel
View all

SPAC IPO Terms Tracker: November 6, 2026

Terms Tracker for the Week Ending November 6, 2026 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week's pricings. There were no IPOs priced this week, so the November monthly IPO count starts at zero, but deal announcements did the heavy lifting with five business combinations announced. ...
Kristi Marvin · Nov 7

Armada III (AACI) to Combine with Brains Bioceutical in $892M Deal

Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. ...

Morning SPAC News Roundup: November 6, 2026

At the SPAC of Dawn A familiar name was appended to the prospectus of the latest SPAC to file for an IPO as Kartoon Studios (NYSE:KACQ.U) put in its paperwork yesterday. It is to be underwritten by EF Hutton, making it the first SPAC to carry that name since the firm went through high-profile split among its management in November 2024. ...

BHAV I (BHAV) to Combine with Nemi Corp. in $400M Deal

BHAV I (NASDAQ:BHAV) has entered into a definitive agreement to combine with automated manufacturing firm Nemi Corp. at a pre-money equity value of $400 million. India-based Nemi is developing software and hardware for autonomous manufacturing that it plans to provide as a service to enterprise clients. ...
New S-1 Filings
View all

New SPAC: Redwoods Acquisition Corp II Files for $75M IPO

Redwoods II has filed for a $75 million SPAC with an Asia-based team focused on the energy storage, telecom and consumer sectors. The new SPAC is offering investors one full warrant and one right to a 1/4 share, which is notably generous, but this has also been roughly the going rate for this corner of the market lately. ...
SPACs In The News
View all